TOXOPLASMOSIS RESEARCH INSTITUTE
Income Statement
Fiscal Year Start:
Jan 1
Revenues in 2024
$189,334
Contributions
>99%
Other
<1%
Investments
<1%
Government Grants
0%
Fundraising Events
0%
Program Services
0%
Membership Dues
0%
Expenses in 2024
$54,181
Grants
83%
Depreciation
8%
Other
5%
Fees to Service Providers
3%
Benefits to Members
0%
Salaries & Benefits
0%
Advertising & Promotion
0%
Offices, Occupancy & IT
0%
Interest
0%
Revenues
2023
2024
Change
Contributions
$73,304
$189,238
+158%
Government Grants
$0
$0
-
Fundraising Events
$0
$0
-
Program Services
$0
$0
-
Membership Dues
$0
$0
-
Investments
$2
$9
+350%
Other
-$586
$87
-115%
Total Revenues
$72,720
$189,334
+160%
Expenses
2023
2024
Change
Grants
$108,000
$45,000
-58%
Benefits to Members
$0
$0
-
Salaries & Benefits
$0
$0
-
Fees to Service Providers
$1,088
$1,861
+71%
Advertising & Promotion
$0
$0
-
Offices, Occupancy & IT
$0
$0
-
Interest
$0
$0
-
Depreciation
$0
$4,502
-
Other
$8,072
$2,818
-65%
Total Expenses
$117,160
$54,181
-54%
Net income
2023
2024
Change
Net income
-$44,440
+$135,153
-404%
Functional Expenses
Summary
2023
2024
Change
Program
-
$47,263
-
Admin
-
$6,918
-
Fundraising
-
$0
-
Total Expenses
$117,160
$54,181
-54%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)